RDNT

AI Memo

RadNet

As of 2026-09-17/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-17 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

6‑12m

Key catalyst

Raised 2026 Imaging Center outlook • 2026-12-31

Base target: $88 / p=55% prob

Biggest risk

The shares already reflect much of the Q2 improvement. Adjusted EPS declined year over year, Digital Health adjusted EBITDA fell to $2.5 million amid investment, labor shortages remain a cost pressure, and acquisition-led expansion introduces execution and capital-allocation risk.

Invalidation

Break below $56 or thesis failure.

What would change my mind?

Record revenue and adjusted EBITDA, higher Imaging Center guidance, 9.6% same-center advanced-imaging growth and rapidly expanding Digital Health ARR support continued earnings growth and strategic optionality. [#SEC-8K-2026-08-10]

Research note

Recommendation

—

Confidence

medium

As of

2026-09-17

Base target

$88

p=55%

Bull target

$101

p=25%

Bear target

$56

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Advanced-imaging volume and mix expansion
Digital Health recurring-revenue scaling
Record revenue and adjusted EBITDA, higher Imaging Center guidance, 9.6% same-center advanced-imaging growth and rapidly expanding Digital Health ARR support continued earnings growth and strategic optionality.

BearKey bullets

A slowdown in advanced-imaging volumes or an unfavorable procedure mix could undermine raised Imaging Center guidance.
Acquisitions and health-system expansion may create integration, execution and capital-allocation risk despite the reported 1.8x net-debt-to-adjusted-EBITDA ratio.
Digital Health growth requires continued commercial, service and implementation spending; segment adjusted EBITDA declined year over year despite strong revenue growth.

WatchKey bullets

Raised 2026 Imaging Center outlook

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $88 (p=55%)

Target spread vs base: +15% / -36%

Scenario probabilities

Bull Target: $101 (p=25%)Base Target: $88 (p=55%)Bear Target: $56 (p=20%)

Commentary

Primary-source news tone is constructive following record Q2 revenue and adjusted EBITDA, higher Imaging Center guidance, and strong advanced-imaging and Digital Health growth. The $75.78 anchor is above the pre-earnings price cited in stored coverage, indicating favorable price follow-through, but the packet does not provide a clean event-day return or evidence linking the full move to earnings. Social coverage is insufficient, while options skew, short interest, employee-review data and post-print analyst revisions are unavailable; zero-valued fields indicate missing evidence rather than neutral readings. Loose peers and incomplete valuation coverage constrain confidence.

As of 2026-09-17 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Advanced-imaging volume and mix expansion
Digital Health recurring-revenue scaling

Scenarios

Bull Target (Scenario probability)

$101 / p=25% prob

Base Target (Scenario probability)

$88 / p=55% prob

Bear Target (Scenario probability)

$56 / p=20% prob

Analysis 2026-09-17 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-31
Raised 2026 Imaging Center outlook
After record second-quarter revenue of $622.7 million and adjusted EBITDA of $99.7 million, RadNet raised 2026 Imaging Center revenue, adjusted EBITDA and free-cash-flow guidance while reaffirming Digital Health guidance. Execution against the higher ranges is the principal year-end checkpoint. [#SEC-8K-2026-08-10]
Prob 82.00% • Move 6.00% • Priced-in 70.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

Advanced-imaging volume and mix expansion
2026-12-31
Aggregate advanced-imaging volume increased 21.2%, same-center advanced-imaging volume rose 9.6%, and advanced imaging reached 29.9% of procedures versus 27.5% one year earlier. Sustained volume and mix gains could support center-level growth and margins. [#SEC-8K-2026-08-10]
Prob 74% • Move 11% • Priced-in 58%
Digital Health recurring-revenue scaling
2026-12-31
Digital Health revenue increased 56.5% year over year and ARR reached $105.5 million, versus $53.5 million one year earlier. Further progress toward management's reported year-end ARR objective could improve the segment's strategic value, although infrastructure investment is suppressing near-term profitability. [#SEC-8K-2026-08-10]
Prob 64% • Move 10% • Priced-in 52%

Risks

A slowdown in advanced-imaging volumes or an unfavorable procedure mix could undermine raised Imaging Center guidance.
Acquisitions and health-system expansion may create integration, execution and capital-allocation risk despite the reported 1.8x net-debt-to-adjusted-EBITDA ratio.
Digital Health growth requires continued commercial, service and implementation spending; segment adjusted EBITDA declined year over year despite strong revenue growth.
Several June 2026 open-market insider sales are documented, but the packet does not establish motive and they should not be interpreted as operating evidence. [#SEC-FORM4-2026-06-16] [#SEC-FORM4-2026-06-18] [#SEC-FORM4-2026-06-22]
Technologist and radiologist shortages could sustain salary pressure and limit margin conversion.

Peers

Symbol	Summary
LNTH	Similar in market capitalization and exposed to diagnostic imaging, but its radiopharmaceutical model differs materially from RadNet's outpatient-center and imaging-software operations; valuation comparisons require caution.
BLCO	Similar in market capitalization but focused on eye-care products rather than imaging-center services, making it only a loose sector comparator.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-17

Loading AI feed…

Symbol

Summary

LNTH

Similar in market capitalization and exposed to diagnostic imaging, but its radiopharmaceutical model differs materially from RadNet's outpatient-center and imaging-software operations; valuation comparisons require caution.

BLCO

Similar in market capitalization but focused on eye-care products rather than imaging-center services, making it only a loose sector comparator.